AF488 Anti-Human CD197/CCR7 Antibody[G043H7]

Introducing the AF488 Anti-Human CD197/CCR7 Antibody [G043H7], a highly specialized and meticulously crafted product designed to cater to the discerning needs of scientific research and experimentation. This antibody, labeled with AF488, offers an exceptional level of specificity and sensitivity in detecting and quantifying the CD197/CCR7 protein in human samples.

The AF488 Anti-Human CD197/CCR7 Antibody [G043H7] is meticulously developed using cutting-edge technology and rigorous quality control measures to ensure optimal performance and reliability. Its unique formulation guarantees minimal cross-reactivity, thereby enabling accurate and precise results in various applications, including flow cytometry, immunofluorescence, and immunohistochemistry.

This antibody's exceptional affinity for the CD197/CCR7 protein allows for the identification and characterization of this crucial cell surface receptor, which plays a pivotal role in immune cell migration and homing. By targeting CD197/CCR7, researchers can gain valuable insights into lymphocyte trafficking, immune response modulation, and the pathogenesis of various diseases, including cancer and autoimmune disorders.

The AF488 Anti-Human CD197/CCR7 Antibody [G043H7] exhibits remarkable versatility, making it an indispensable tool for a wide range of scientific investigations. Its compatibility with multiple sample types, including blood, tissue, and cell cultures, ensures its applicability across diverse research fields, such as immunology, oncology, and infectious diseases.

With its exceptional performance, stringent quality control, and broad applicability, the AF488 Anti-Human CD197/CCR7 Antibody [G043H7] stands as an invaluable asset for researchers seeking to unravel the intricate mechanisms underlying immune cell migration and its implications in various pathological conditions. Trust in this meticulously crafted antibody to deliver accurate and reproducible results, empowering your scientific endeavors and driving advancements in biomedical research.